US equities
|
SPCX
$167.10
▲+5.12%
NVDA
$236.34
▲+1.02%
MU
$1,064.55
▼-0.96%
TSLA
$378.75
▲+2.20%
MSFT
$525.17
▲+1.48%
SNDK
$1,709.30
▼-0.62%
INTC
$117.39
▼-1.63%
META
$743.82
▲+2.16%
SPCX
$167.10
▲+5.12%
NVDA
$236.34
▲+1.02%
MU
$1,064.55
▼-0.96%
TSLA
$378.75
▲+2.20%
MSFT
$525.17
▲+1.48%
SNDK
$1,709.30
▼-0.62%
INTC
$117.39
▼-1.63%
META
$743.82
▲+2.16%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Achieve Life Sciences, Inc. - Common Shares
(NQ:
ACHV
)
7.010
-0.230 (-3.18%)
Delayed Quote
Updated: 12:24 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Achieve Life Sciences, Inc. - Common Shares
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 11, 2021
Gainers Hims & Hers Health (NYSE:HIMS)...
Via
Benzinga
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
August 11, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 11, 2021
Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
August 11, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Why Achieve Life Sciences' Stock is Trading Lower Today
↗
May 25, 2021
Achieve Life Sciences (NASDAQ:ACHV) shares are tradin...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
↗
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
August 03, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
July 22, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
June 29, 2021
ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE /...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
↗
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2021
↗
June 23, 2021
Upgrades B of A Securities upgraded the previous rating for UGI Corp (NYSE:UGI) from Neutral to Buy. UGI earned $1.99 in the second quarter, compared to $1.56 in the year-...
Via
Benzinga
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
June 03, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
June 02, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 27, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
54 Biggest Movers From Yesterday
↗
May 26, 2021
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...
Via
Benzinga
Mid-Afternoon Market Update: Dycom Industries Drops Following Q1 Results; The Joint Corp Shares Slide
↗
May 25, 2021
Toward the end of trading Tuesday, the Dow traded down 0.09% to 34,362.49 while the NASDAQ fell 0.04% to 13,655.88. The S&P also fell, dropping 0.14% to 4,191.36. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 25, 2021
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's...
Via
Benzinga
Mid-Day Market Update: US Stocks Turn Lower; Provention Bio Shares Surge
↗
May 25, 2021
Midway through trading Tuesday, the Dow traded down 0.16% to 34,337.29 while the NASDAQ fell 0.16% to 13,638.63. The S&P also fell, dropping 0.20% to 4,188.77. The U.S. has...
Via
Benzinga
Topics
Stocks
42 Stocks Moving In Tuesday's Mid-Day Session
↗
May 25, 2021
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's...
Via
Benzinga
Achieve Life Sciences Stock Plunges After Raising $20M Via Equity at 19% Discount
↗
May 25, 2021
Achieve Life Sciences Inc (NASDAQ: ACHV) has priced its underwritten public offering of 2.9 million at $7 per share, representing a discount of 19% from the last...
Via
Benzinga
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
May 25, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 25, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
↗
May 25, 2021
Gainers U.S. Well Services, Inc. (NASDAQ: USWS) rose 30.5% to $1.25 in pre-market trading after the company reported commitment to becoming all-electric hydraulic facturing...
Via
Benzinga
7 Stocks Moving In Monday's After-Hours Session
↗
May 24, 2021
Gainers Scholar Rock (NASDAQ: SRRK) shares are trading higher after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 24, 2021
Gainers OptiNose (NASDAQ:OPTN) stock rose...
Via
Benzinga
Achieve Life Sciences Announces Proposed Underwritten Public Offering
May 24, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 24, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
May 13, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
↗
May 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
